Morgan Stanley Anika Therapeutics, Inc. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 701,732 shares of ANIK stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
701,732
Previous 485,093
44.66%
Holding current value
$17.8 Million
Previous $11 Million
62.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ANIK
# of Institutions
119Shares Held
11.9MCall Options Held
5.9KPut Options Held
6.3K-
Trigran Investments, Inc.2.07MShares$52.5 Million5.1% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$39.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX810KShares$20.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA774KShares$19.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny560KShares$14.2 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $370M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...